KPWS
AQST icon

Kestra Private Wealth Services’s Aquestive Therapeutics AQST Stock Holding History

Kestra Private Wealth Services’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Hold
10,750
– – ﹤0.01% 1773
2026
Q1 		$44.6K Hold
10,750
– – ﹤0.01% 1714
2025
Q4 		$69.4K Hold
10,750
– – ﹤0.01% 1675
2025
Q3 		$60.1K Buy
+10,750
New +$46.5K ﹤0.01% 1628
2023
Q3 		– Sell
-16,732
Closed -$27.6K – 1170
2023
Q2 		$27.6K Buy
+16,732
New +$30.3K ﹤0.01% 1063

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Kestra Private Wealth Services's AQST Position: Q2 2026 in Review

Kestra Private Wealth Services held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 10,750 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Kestra Private Wealth Services first reported a position in AQST in Q2 2023 and has held it in 5 quarters since. The position peaked at $69.4K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Kestra Private Wealth Services held 10,750 shares of Aquestive Therapeutics worth $44.7K as of Q2 2026.
  • Kestra Private Wealth Services left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1773 holding.
  • Kestra Private Wealth Services first reported a position in Aquestive Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • Kestra Private Wealth Services's Aquestive Therapeutics position peaked at $69.4K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.